BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2887100)

  • 1. Beta blockade early in acute myocardial infarction.
    Sleight P
    Am J Cardiol; 1987 Jul; 60(2):6A-10A. PubMed ID: 2887100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.
    Lancet; 1986 Jul; 2(8498):57-66. PubMed ID: 2873379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of beta adrenoceptor blockade during and after acute myocardial infarction.
    Sleight P
    Annu Rev Med; 1986; 37():415-25. PubMed ID: 2871805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group.
    Lancet; 1988 Apr; 1(8591):921-3. PubMed ID: 2895838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial.
    Yusuf S; Ramsdale D; Peto R; Furse L; Bennett D; Bray C; Sleight P
    Lancet; 1980 Aug; 2(8189):273-6. PubMed ID: 6105436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate.
    Wilcox RG
    Acta Med Scand Suppl; 1981; 651():193-202. PubMed ID: 6119875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockade in acute myocardial infarction.
    Cruickshank JM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 1():S59-70. PubMed ID: 2468837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.
    Yusuf S; Sleight P; Rossi P; Ramsdale D; Peto R; Furze L; Sterry H; Pearson M; Motwani R; Parish S; Gray R; Bennett D; Bray C
    Circulation; 1983 Jun; 67(6 Pt 2):I32-41. PubMed ID: 6851037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention of cardiac events following myocardial infarction: effects of atenolol and enalapril. Beijing Collaborative Study Group.
    Wu N; Fan Z
    Chin Med J (Engl); 1997 Aug; 110(8):602-6. PubMed ID: 9594263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.
    Rossi PR; Yusuf S; Ramsdale D; Furze L; Sleight P
    Br Med J (Clin Res Ed); 1983 Feb; 286(6364):506-10. PubMed ID: 6186329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention after myocardial infarction: in favor of beta-blockers.
    Lévy S
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S50-4. PubMed ID: 1707116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta blockade in acute myocardial infarction].
    Bosković D; Terzić B; Perunicić J; Zugić M; Beleslin BD
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():17-24. PubMed ID: 18196643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do results from major clinical trials indicate a change in management in the acute phase of myocardial infarction?
    Hjalmarson A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S2-8; discussion S9. PubMed ID: 2481164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol.
    Ramsdale DR; Faragher EB; Bennett DH; Bray CL; Ward C; Cruickshank JM; Yusuf S; Sleight P
    Am Heart J; 1982 Apr; 103(4 Pt 1):459-67. PubMed ID: 6121479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.
    Wilcox RG; Roland JM; Banks DC; Hampton JR; Mitchell JR
    Br Med J; 1980 Mar; 280(6218):885-8. PubMed ID: 6992916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction.
    Gottlieb SS; McCarter RJ
    Am J Cardiol; 2001 Apr; 87(7):823-6. PubMed ID: 11274934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophilic versus hydrophilic beta(1) blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction.
    Kardos A; Long V; Bryant J; Singh J; Sleight P; Casadei B
    Heart; 1998 Feb; 79(2):153-60. PubMed ID: 9538308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous beta-blockade during acute myocardial infarction.
    Lancet; 1986 Jul; 2(8498):79-80. PubMed ID: 2873383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.